Qingui Chen, MD PhD

Post doc
Leiden University Medical Center
Leiden, Zuid-Holland, Netherlands

Qingui Chen is a postdoctoral fellow at the Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, the Netherlands. He studied medicine in China, and completed his PhD studies between 2019 and 2023 in Leiden University Medical Center. Currently his research focuses on using routinely collected population/medical data to conduct clinical epidemiological research, especially on antithrombotic therapy and arterial/venous thromboembolic complications.

Presentation(s):

PB0003 - Time trends in vitamin K antagonist (VKA) treatment in the Netherlands in an era of transition to DOACs and lowering of VKA target intensity

Sunday, June 23, 2024
13:45 – 14:45 ICT
OC 23.3 - Concurrent use of novel antidiabetic drugs and risks of adverse events among atrial fibrillation patients receiving chronic anticoagulation

Sunday, June 23, 2024
15:15 – 15:30 ICT
OC 23.4 - Long-term maternal risk of cardiovascular diseases after pregnancy in the era of increasing aspirin use for preventing preeclampsia: A nationwide population-based study in the Netherlands

Sunday, June 23, 2024
15:30 – 15:45 ICT
OC 31.5 - Time trends (2013-2019) in antithrombotic therapy prescriptions and thromboembolic complications during the postpartum period in the Netherlands: a nationwide study

Monday, June 24, 2024
10:30 – 10:45 ICT
PB0983 - Frequency of discontinuation of vitamin K antagonists and occurrence of bleeding and thromboembolic events in long-term users with a limited life expectancy

Tuesday, June 25, 2024
13:45 – 14:45 ICT
PB1412 - Thromboembolic and bleeding events and use of antithrombotic therapy in patients with advanced cancer: a Dutch nationwide cohort study from the SERENITY consortium

Tuesday, June 25, 2024
13:45 – 14:45 ICT
PB0981 - Vitamin K antagonist treatment quality in the last year of life: a multicentre observational cohort

Tuesday, June 25, 2024
13:45 – 14:45 ICT